Home › Colon Cancer › Illinois › Peoria
Colon Cancer clinical trials in Peoria, IL
4 studies for Colon Cancer are looking for participants at sites in and around Peoria (within about 30 miles). Open a study to see who can join and how to contact the study team.
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Illinois Cancer Care, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Illinois CancerCare-Peoria, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- Illinois CancerCare-Canton, Canton · 25 mi away
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RecruitingPhase 2/3
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- and 1 more
Family Communications After Genetic Testing
RecruitingHealthy volunteers welcome
- Illinois CancerCare-Peoria, Peoria
- Methodist Medical Center of Illinois, Peoria
- Illinois CancerCare-Pekin, Pekin · 9 mi away
- and 1 more
Colon Cancer trials in other cities
- Boston, MA22 studies
- New York City, NY22 studies
- Houston, TX20 studies
- Nashville, TN16 studies
- Los Angeles, CA16 studies
- Arlington, VA15 studies
- St. Louis, MO15 studies
- San Antonio, TX14 studies
- Tampa, FL13 studies
- Baldwin Park, CA13 studies
- Baltimore, MD13 studies
- Chicago, IL13 studies
Other studies in Peoria
- Non-Small Cell Lung Cancer21 studies
- Colorectal Cancer12 studies
- Lung Cancer12 studies
- Prostate Cancer9 studies
- Breast Cancer8 studies
- Heart Failure8 studies
- Metastatic Cancer7 studies
- Ovarian Cancer7 studies
- Pancreatic Cancer7 studies
- Cancer (all types)7 studies
- Head and Neck Squamous Cell Carcinoma7 studies
- Endometrial Cancer6 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.